Skip to main content
Local News

CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

By January 18, 2018No Comments

CannaRoyalty Corp.  and Aequus Pharmaceuticals Inc. today announced a collaboration (the “JV”) to advance a suite of cannabis-based therapies targeting neurological disorders into clinical trials in Canada, in collaboration with Canadian doctors and key opinion leaders.

CannaRoyalty and Aequus have formed this collaboration to clinically advance a number of cannabis-based therapies in partnership with Canadian clinicians to create truly differentiated products supported by clinical data focused on the medical community. The collaboration will leverage CannaRoyalty’s deep expertise in identifying, funding and commercializing cannabis related products in California and Aequus’ expertise in clinical development and drug delivery, and commercializing differentiated therapeutics in Canada.